The transforming growth factor-β (TGF-β) signaling pathway is a central driver in the pathogenesis of pulmonary fibrosis (PF), and strategies targeting this pathway demonstrate therapeutic potential. Here, TGFB1 is linked to pemphigus foliaceus.